Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aberrant Crypt Foci”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableEnded earlyNCT00176618
What this trial is testing

The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon

Who this might be right for
Aberrant Crypt Foci
University of Medicine and Dentistry of New Jersey 60
Not applicableStudy completedNCT00623883
What this trial is testing

Colonoscopic Removal of Aberrant Crypt Foci: a Prospective, Randomized, Blinded Trial

Who this might be right for
Colorectal Neoplasms
National Naval Medical Center 98
Testing effectiveness (Phase 2)Study completedNCT00365209
What this trial is testing

Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)

Who this might be right for
Healthy, no Evidence of DiseaseTobacco Use Disorder
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT00754494
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma

Who this might be right for
Adenomatous PolypRecurrent Colon CancerRecurrent Rectal Cancer+14 more
National Cancer Institute (NCI) 45